Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Antidiabetic Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Antidiabetic Drugsmarket, defines the market attractiveness level of Antidiabetic Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Antidiabetic Drugs industry, describes the types of Antidiabetic Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Antidiabetic Drugs market and the development prospects and opportunities of Antidiabetic Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Antidiabetic Drugs market in Chapter 13.
By Player:
Novartis
Takeda
Sanofi
Pfizer
AstraZeneca
Merck
Eli Lilly
Boehringer Ingelheim
Bayer
Novo Nordisk
By Type:
Oral Drugs
Injectable Drugs
By End-User:
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes Mellitus
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Antidiabetic Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Antidiabetic Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Antidiabetic Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Antidiabetic Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Antidiabetic Drugs Market Analysis and Outlook to 2022
-
7.1 Global Antidiabetic Drugs Consumption (2017-2022)
-
7.2 United States Antidiabetic Drugs Consumption (2017-2022)
-
7.3 Europe Antidiabetic Drugs Consumption (2017-2022)
-
7.4 China Antidiabetic Drugs Consumption (2017-2022)
-
7.5 Japan Antidiabetic Drugs Consumption (2017-2022)
-
7.6 India Antidiabetic Drugs Consumption (2017-2022)
-
7.7 South Korea Antidiabetic Drugs Consumption (2017-2022)
8 Region and Country-wise Antidiabetic Drugs Market Analysis and Outlook to 2028
-
8.1 Global Antidiabetic Drugs Consumption Forecast (2022-2028)
-
8.2 United States Antidiabetic Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Antidiabetic Drugs Consumption Forecast (2022-2028)
-
8.4 China Antidiabetic Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Antidiabetic Drugs Consumption Forecast (2022-2028)
-
8.6 India Antidiabetic Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Antidiabetic Drugs Consumption Forecast (2022-2028)
9 Global Antidiabetic Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Antidiabetic Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oral Drugs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Injectable Drugs Consumption and Growth Rate (2017-2022)
-
9.2 Global Antidiabetic Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Type 1 Diabetes Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Gestational Diabetes Mellitus Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Antidiabetic Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Antidiabetic Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Oral Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Injectable Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Antidiabetic Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Type 1 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Gestational Diabetes Mellitus Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Antidiabetic Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Antidiabetic Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Antidiabetic Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Antidiabetic Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Antidiabetic Drugs Market Competitive Analysis
-
14.1 Novartis
-
14.1.1 Novartis Company Details
-
14.1.2 Novartis Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis Antidiabetic Drugs Product and Service
-
14.2 Takeda
-
14.2.1 Takeda Company Details
-
14.2.2 Takeda Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Takeda Antidiabetic Drugs Product and Service
-
14.3 Sanofi
-
14.3.1 Sanofi Company Details
-
14.3.2 Sanofi Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Sanofi Antidiabetic Drugs Product and Service
-
14.4 Pfizer
-
14.4.1 Pfizer Company Details
-
14.4.2 Pfizer Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Pfizer Antidiabetic Drugs Product and Service
-
14.5 AstraZeneca
-
14.5.1 AstraZeneca Company Details
-
14.5.2 AstraZeneca Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 AstraZeneca Antidiabetic Drugs Product and Service
-
14.6 Merck
-
14.6.1 Merck Company Details
-
14.6.2 Merck Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Merck Antidiabetic Drugs Product and Service
-
14.7 Eli Lilly
-
14.7.1 Eli Lilly Company Details
-
14.7.2 Eli Lilly Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Eli Lilly Antidiabetic Drugs Product and Service
-
14.8 Boehringer Ingelheim
-
14.8.1 Boehringer Ingelheim Company Details
-
14.8.2 Boehringer Ingelheim Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Boehringer Ingelheim Antidiabetic Drugs Product and Service
-
14.9 Bayer
-
14.9.1 Bayer Company Details
-
14.9.2 Bayer Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Bayer Antidiabetic Drugs Product and Service
-
14.10 Novo Nordisk
-
14.10.1 Novo Nordisk Company Details
-
14.10.2 Novo Nordisk Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Novo Nordisk Antidiabetic Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Antidiabetic Drugs
-
Figure Antidiabetic Drugs Picture
-
Table Global Antidiabetic Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Antidiabetic Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Antidiabetic Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Antidiabetic Drugs Consumption by Country (2017-2022)
-
Figure United States Antidiabetic Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Antidiabetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Antidiabetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Antidiabetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Antidiabetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Antidiabetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Antidiabetic Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Antidiabetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Antidiabetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Antidiabetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Antidiabetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Antidiabetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Antidiabetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Injectable Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Type 1 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Gestational Diabetes Mellitus Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injectable Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type 1 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gestational Diabetes Mellitus Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Antidiabetic Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Antidiabetic Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Antidiabetic Drugs Product and Service
-
Table Takeda (Foundation Year, Company Profile and etc.)
-
Table Takeda Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Antidiabetic Drugs Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Antidiabetic Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Antidiabetic Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Antidiabetic Drugs Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Antidiabetic Drugs Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Antidiabetic Drugs Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Antidiabetic Drugs Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Antidiabetic Drugs Product and Service
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Antidiabetic Drugs Product and Service
-
